From a horizontal accumulation phase, the timing seems good to buy shares in Renault and to get ahead of a break-out on the upside of the congestion area. Investors have an opportunity to buy the stock and target the € 98.75.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 85.87 EUR in weekly data.
The group usually releases upbeat results with huge surprise rates.
The stock, which is currently worth 2018 to 0.36 times its sales, is clearly overvalued in comparison with peers.
Its low valuation, with P/E ratio at 5.51 and 5.28 for the ongoing fiscal year and 2019 respectively, makes the stock pretty attractive with regard to earnings multiples.
This company will be of major interest to investors in search of a high dividend stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The tendency within the weekly time frame is positive above the technical support level at 85.87 EUR
According to forecast, a sluggish sales growth is expected for the next fiscal years.
Revenue estimates are regularly revised downwards for the current and coming years.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.